4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000110
Chief Medical Officer sold 4,007 shares at $37.56 ($150,503)
- Chief Medical Officer acquired 8,375 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,375 | 88,652 | D | ||
| 2026-07-01 | Sale : show line 2 in the form 10b5-1 | −4,007 | $37.56 | $150,503 | 84,645 | D |
| Open-market sales · 4,007 sh · avg $37.56 · $150,503 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −8,375 | 0 | D |
Loading xslF345X06/wk-form4_1783022592.xml…